RecruitingNot ApplicableNCT05888571

Pre-pectoral Breast Reconstruction With or Without Mesh

A Randomized Controlled Trial of Prepectoral Breast Reconstruction With and Without Mesh


Sponsor

Tianjin Medical University Cancer Institute and Hospital

Enrollment

164 participants

Start Date

Jul 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

To explore the efficacy and safety that occur after immediate prepectoral breast reconstruction when TiLOOP Mesh is used compared to that when TiLOOP Mesh is not used.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Tiloop Mesh implantation and a procedure called prepectoral breast reconstruction for people with prepectoral breast reconstruction and tiloop mesh. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREprepectoral breast reconstruction

Patients receive immediate prepectoral breast reconstruction

PROCEDURETiloop Mesh implantation

Patients receive immediate prepectoral breast reconstruction with Tiloop Mesh


Locations(1)

Tianjin Medical University Cancer Institute and Hospital

Tianjin, Tianjin Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05888571


Related Trials